Russia to allow imported drugs that have not undergone clinical trials in the country

The Russian government plans to provide access to imported drugs that have not undergone clinical trials within Russia, according to recent statements by some senior officials of the Russian Ministry of Health, reports The Pharma Letter's local correspondent.

This will apply to drugs from countries of the European Union, as well as the USA and Japan and will be part of the existing roadmap "Development of Competition in Public Health," which has been recently approved by the Russian government, The Pharma Letter’s local correspondent reports.

A spokesman for Russian Minister of Health Veronika Skvortsova said this measure will provide domestic patients with better access to new drugs.